What causes Parkinson's disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What Causes Parkinson's Disease?

Parkinson's disease is caused by a complex interplay of aging, genetic susceptibility, and environmental factors, with the pathological hallmark being progressive degeneration of dopaminergic neurons in the substantia nigra and accumulation of alpha-synuclein protein in Lewy bodies. 1, 2

Primary Pathophysiological Mechanism

Parkinson's disease is fundamentally a synucleinopathy characterized by abnormal cytoplasmic inclusions of alpha-synuclein protein forming Lewy bodies within neurons 1. The core pathological process involves:

  • Progressive loss of dopaminergic neurons in the substantia nigra pars compacta, leading to striatal dopamine deficiency and disruption of the basal ganglia-thalamo-cortical circuit 1, 3
  • Clinical symptoms emerge only after approximately 40-50% of dopaminergic neurons have been lost, with an estimated 5-year interval between initial neuronal loss and symptom appearance 4, 1
  • Mitochondrial dysfunction, particularly decreased activity of respiratory chain Complex I, represents a key pathophysiological feature 1, 5

Multifactorial Etiology

Aging as the Primary Risk Factor

  • Age is the strongest risk factor, with prevalence rising exponentially after age 60, peaking between 60-70 years 4, 2
  • Aging impairs cellular pathways that protect dopaminergic neurons, increasing susceptibility to cell death 2
  • However, the majority of individuals over age 80 do not develop PD, indicating that aging alone is insufficient to cause disease 2

Genetic Contributions

Genetic factors account for approximately 30% of PD heritability, but pure Mendelian causes represent only 5% of cases 2, 6:

  • Familial cases comprise nearly one-third of all PD, with a small subset showing autosomal dominant inheritance 7
  • Key genes implicated include SNCA (alpha-synuclein), LRRK2, GBA, parkin, DJ-1, and PINK-1 2, 3, 5
  • Common genetic polymorphisms are associated with only small increases in PD risk 2
  • Mitochondrial DNA anomalies have also been identified, suggesting mitochondrial genetic contributions 7

Environmental Factors

Environmental exposures contribute to PD risk, though causality remains incompletely established 2, 6:

  • Rural residence and pesticide exposure increase PD risk 7, 3
  • The synthetic drug MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) can cause parkinsonism, suggesting environmental neurotoxins may play a role 7
  • Genes regulating drug and neurotoxin metabolism show modest associations with PD susceptibility 7
  • However, the absence of geographic clusters and conjugal cases argues against environmental toxins as a major sole cause 2

Converging Molecular Pathways

The following mechanisms represent common pathways regardless of initial trigger 2, 5:

  • Mitochondrial dysfunction and oxidative stress compromise dopaminergic neuronal function 1, 5
  • Impaired autophagy leads to accumulation of misfolded proteins 2
  • Neuroinflammation contributes to progressive neurodegeneration 2
  • Abnormal protein accumulation and phosphorylation, particularly alpha-synuclein, which spreads in a prion-like fashion through brain regions 2, 5

Clinical Implications

Understanding the multifactorial nature of PD is critical because:

  • No single factor alone is sufficient to cause PD in most patients 2, 6
  • The ultimate cause remains unknown for idiopathic PD, which represents the vast majority of cases 3
  • Current therapies only provide symptomatic relief and do not halt dopaminergic neuronal death 5
  • Disease-modifying therapies remain elusive due to incomplete understanding of disease initiation mechanisms 3

References

Guideline

Biochemistry of Parkinson's Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Parkinson's disease: a review.

Frontiers in bioscience (Scholar edition), 2014

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Parkinson's disease.

Human molecular genetics, 2007

Research

Genetic epidemiology of Parkinson's disease.

Journal of geriatric psychiatry and neurology, 1998

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.